Effectiveness of Acupuncture for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis

Qi Huang , Dan Luo , Li Chen , Feng-xia Liang , Rui Chen

Current Medical Science ›› 2019, Vol. 39 ›› Issue (3) : 500 -511.

PDF
Current Medical Science ›› 2019, Vol. 39 ›› Issue (3) : 500 -511. DOI: 10.1007/s11596-019-2065-8
Article

Effectiveness of Acupuncture for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis

Author information +
History +
PDF

Abstract

Acupuncture has reportedly improved memory and cognitive impairment in both animal and clinical studies. It may be an effective treatment for Alzheimer’s disease (AD). The purpose of this meta-analysis was to review the effectiveness of acupuncture for the treatment of AD. Eight databases were searched for articles published up to and including July 2017, and 13 studies fulfilling the inclusion criteria were identified. The main outcomes assessed were clinical efficacy rate, Mini-Mental State Examination score, Ability of Daily Living Scale score, Alzheimer’s Disease Assessment Scale-Cognition score, Hasegawa’s Dementia Scale (HDS) score, and adverse events. The methodological quality of the articles was assessed using Cochrane’s risk of bias. All the studies compared the efficacy of acupuncture with that of medication, and were published in Chinese journals. Meta-analysis revealed that acupuncture yielded positive results as determined via all the indexes scored except the HDS (95% CI −0.26 to 0.90, Z=0.35, P=0.73). Only one of the studies reported adverse events associated with acupuncture and medication. The rate of adverse events in the medication group was 13%. In most of the studies assessed in the current meta-analysis, acupuncture alone was better than conventional western medicines for the treatment of AD.

Keywords

acupuncture / medication / meta-analysis / systematic review

Cite this article

Download citation ▾
Qi Huang, Dan Luo, Li Chen, Feng-xia Liang, Rui Chen. Effectiveness of Acupuncture for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis. Current Medical Science, 2019, 39(3): 500-511 DOI:10.1007/s11596-019-2065-8

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

World Health Organization.. Dementia Fact sheet May, 2017

[2]

GBD 2015 DiseaseInjury IncidencePrevalence Collaborators.. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 2016, 388(10053): 1545-1602

[3]

GBD 2013 MortalityCauses of Death Collaborators.. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet, 2015, 385(9963): 117-171

[4]

BurnsA, IliffeS. Dementia. Bmj, 2009, 338(7691): b75

[5]

Sanabria-CastroA, Alvarado-EcheverriaI, Monge-BonillaC. Molecular Pathogenesis of Alzheimer’s Disease: An Update. Ann Neurosci, 2017, 24(1): 46-54

[6]

BiererLM, HaroutunianV, GabrielS, et al.. Neurochemical correlates of dementia severity in Alzheimer’s disease: relative importance of the cholinergic deficits. J Neurochem, 1995, 64(2): 749-760

[7]

CroxsonPL, KyriazisDA, BaxterMG. Cholinergic modulation of a specific memory function of prefrontal cortex. Nat Neurosci, 2011, 14(12): 1510-1512

[8]

PabstM, BraganzaO, DannenbergH, et al.. Astrocyte Intermediaries of Septal Cholinergic Modulation in the Hippocampus. Neuron, 2016, 90(4): 853-865

[9]

SucherNJ, AwobuluyiM, ChoiYB, et al.. NMDA receptors: from genes to channels. Trends Pharmacol Sci, 1996, 17(10): 348-355

[10]

LiptonSA, RosenbergPA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med, 1994, 330(9): 613-622

[11]

BirksJ. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev, 2006, 1: Cd005593

[12]

LleoA, GreenbergSM, GrowdonJH. Current pharmacotherapy for Alzheimer’s disease. Annu Rev Med, 2006, 57(1): 513-533

[13]

McShaneR, Areosa SastreA, MinakaranN. Memantine for dementia. Cochrane Database Syst Rev, 2006, 2: Cd003154

[14]

RolinskiM, FoxC, MaidmentI, et al.. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev, 2012, 3: Cd006504

[15]

KavirajanH, SchneiderLS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol, 2007, 6(9): 782-792

[16]

CourtneyC, FarrellD, GrayR, et al.. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial. Lancet, 2004, 363(9427): 2105-2115

[17]

GustavssonA, BrinckP, BergvallN, et al.. Predictors of costs of care in Alzheimer’s disease: a multinational sample of 1222 patients. Alzheimers Dement, 2011, 7(3): 318-327

[18]

WangXR, ShiGX, YangJW, et al.. Acupuncture ameliorates cognitive impairment and hippocampus neuronal loss in experimental vascular dementia through Nrf2-mediated antioxidant response. Free Radic Biol Med, 2015, 89(9): 1077-1084

[19]

ForbesD, ThiessenEJ, BlakeCM, et al.. Exercise programs for people with dementia. Cochrane Database Syst Rev, 2015, 4: Cd006489

[20]

WangZ, NieB, LiD, et al.. Effect of acupuncture in mild cognitive impairment and Alzheimer disease: a functional MRI study. PLoS One, 2012, 7(8): e42730

[21]

LeeMS, ShinBC, ErnstE. Acupuncture for Alzheimer’s disease: a systematic review. Int J Clin Pract, 2009, 63(6): 874-879

[22]

ZhouJ, PengW, XuM, et al.. The effectiveness and safety of acupuncture for patients with Alzheimer disease: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore), 2015, 94(22): e933

[23]

McKhannG, DrachmanD, FolsteinM, et al.. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 1984, 34(7): 939-944

[24]

MorrisJC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 1993, 43(11): 2412-2414

[25]

American Psychiatric Association.. Diagnostic and Statistical Manual of Mental Disorders, 4th text version (DSM-IV): Washington, DC:APA., 2000943

[26]

World Health Organization.. The ICD-10 Classification of Metal and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, 1992

[27]

FolsteinMF, FolsteinSE, McHughPR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res, 1975, 12(3): 189-198

[28]

De La Diaz-VenegasC, VegaS, WongR. Transitions in activities of daily living in Mexico, 2001–2012. Salud Publica Mex, 2015, 57(Suppl1): S54-S61

[29]

IhlR, FerrisS, RobertP, et al.. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer’s disease. Int J Geriatr Psychiatry, 2012, 27(1): 15-21

[30]

RozziniL, ChiloviBV, ContiM, et al.. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration. Int J Geriatr Psychiatry, 2007, 22(12): 1217-1222

[31]

TsuboiK, HaradaT, IshiiT, et al.. Evaluation of the usefulness of a simple touch-panel method for the screening of dementia. Hiroshima J Med Sci, 2009, 58(2-3): 49-53

[32]

HigginsJP, AltmanDG, GotzschePC, et al.. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Bmj, 2011, 343: d5928

[33]

Higgins JPTGS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 The Cochrane Collaboration, 2011

[34]

HigginsJP, ThompsonSG, DeeksJJ, et al.. Measuring inconsistency in meta-analyses. BMJ, 2003, 327(7414): 557-560

[35]

MilleaP, ReedBR. Acupuncture in the treatment of Alzheimer Disease complicated by agitation: a randomized controlled pilot study. Med Acup, 2004, 15(3): 19-23

[36]

YanXZ, LiZY, HuaQH, et al.. The effect of Tousanshen acupuncture in the treatment of Alzheimer’s disease on plasma Tau protein. J Bengbu Med Coll (Chinese), 2014, 39: 302-306

[37]

ZhaoLG, MaL, LiYJ, et al.. Clinical observation on Alzheimer’s disease treated by Acupuncture Dazhui (GV 14) and Baihui (GV 20). J Clin Acup Moxib (Chinese), 2007, 23(9): 42-43

[38]

ZhuH, DongKL, WuY, et al.. Effect of “Bushenhuoxue” Method on Cognitive Function Improvement of Alzheimer’s Disease Patients. Chin J Gerontol (Chinese), 2010, 30(11): 1493-1495

[39]

JiaYJ, ChenHY, YuT, et al.. Investigation on TCM Syndromes of Alzheimer’s Disease and Clinical Observation of treatment with “Fubenpaiyuan” Acupuncture. The third session of the academic conference of Chinese medicine, integrated traditional Chinese and Western Medicine and Geriatric medicine held by The World Federation of Chinese Medicine: Sichuan Province of China, 2010330-336

[40]

GuW, JinXX, ZhangYJ, et al.. Clinical observation of Alzheimer’s disease treated with acupuncture. Chin Acup Moxib (Chinese), 2014, 34(12): 1156-1160

[41]

WangKF, ZhangLJ, ChenXY. Clinical observation on 36 cases of Alzheimer’s disease treated by electro-acupuncture Dazhui (GV 14) and Baihui (GV 20). Chin J Trad Chin Med Pharm (Chinese), 2015, 30(3): 784-786

[42]

LiuZB, NiuWM, YangXH, et al.. The clinical research of impact on cognitive function of patients with Alzheimer’s disease by using Xiu Sanzhen. Shan Xi J Traditional Chin Med (Chinese), 2008, 29(6): 711-712

[43]

KeYM. Clinical Research on Acupuncture Treatment of Qi and Blood Deficiency type Senile Dementia. Heilongjiang Univ Chin Med (Chinese), 20142-54

[44]

LinH. Clinical study on treating Alzheimer’s Disease with “Yi Zhi Si Xiang” scalp acupuncture. Guangzhou Univ Chin Med (Chinese), 201693-94

[45]

LiuJ. Effect of Chinese Herbs Combined with Acupuncture on the Expression of Peripheral Blood TNF-α and IL-6 in Patients with Alzheimer’s Disease. Med Innov China (Chinese), 2015, 12(30): 93-95

[46]

ZhuYY. Observations on the Therapeutic Effect of Warm Needling on Senile Dementia. Shanghai J Acu-Mox (Chinese), 2014, 33(11): 996-997

[47]

LinCR, ZhangJX, GuoJK, et al.. Clinical observation on 18 cases of mild Alzheimer’s disease treated by “Tiaoshenyizhi” acupuncture. Chin J Gerontol (Chinese), 2014, 34(8): 2225-2226

[48]

OuYQ, LiZR, MuYY, et al.. Clinical Study on Acupuncture Treatment of Alzheimer’s Disease. Chin Acup Mox (Chinese), 1999, 7: 399-401

[49]

LiZR, MuYY, OuYQ. Clinic control research of Alzheimer’s disease by the combination of acupuncture and Danggui Shaoyao San (DGSYS) of TCM. Chin J Clin Rehab (Chinese), 2002, 6(19): 2848-2849

[50]

O’BrienJT, HolmesC, JonesM, et al.. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol, 2017, 31(2): 147-168

[51]

DingX, YuJ, YuT, et al.. Acupuncture regulates the aging-related changes in gene profile expression of the hippocampus in senescence-accelerated mouse (SAMP10). Neurosci Lett, 2006, 399(1-2): 11-16

[52]

HwangIK, ChungJY, YooDY, et al.. Comparing the effects of acupuncture and electroacupuncture at Zusanli and Baihui on cell proliferation and neuroblast differentiation in the rat hippocampus. J Vet Med Sci, 2010, 72(3): 279-284

[53]

HwangIK, ChungJY, YooDY, et al.. Effects of electroacupuncture at Zusanli and Baihui on brain-derived neurotrophic factor and cyclic AMP response element-binding protein in the hippocampal dentate gyrus. J Vet Med Sci, 2010, 72(11): 1431-1436

[54]

LiG, ZhangX, ChengH, et al.. Acupuncture improves cognitive deficits and increases neuron density of the hippocampus in middle-aged SAMP8 mice. Acupunct Med, 2012, 30(4): 339-345

[55]

LiuQ, ZerbinattiCV, ZhangJ, et al.. Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1. Neuron, 2007, 56(1): 66-78

[56]

LiuZB, NiuWM, YangXB, et al.. Effect of “Xiusanzhen” on expression of hippocampal Bcl-2 and Bax proteins in Alzheimer disease rats. Zhen Ci Yan Jiu (Chinese), 2011, 36(1): 7-11

[57]

ShibataM, YamadaS, KumarSR, et al.. Clearance of Alzheimer’s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest, 2000, 106(12): 1489-1499

[58]

WangZ, LiangP, JiaX, et al.. The baseline and longitudinal changes of PCC connectivity in mild cognitive impairment: a combined structure and resting-state fMRI study. PLoS One, 2012, 7(5): e36838

[59]

XueWG, GeGL, ZhangZ, et al.. Effect of electroacupuncture on the behavior and hippocampal ultrastructure in APP 695 V 717 I transgenic mice. Zhen Ci Yan Jiu (Chinese), 2009, 34(5): 309-314

[60]

YangXH, LiuZB, NiuWM, et al.. Effect of “Xiusanzhen” on hippocampal muscarinic cholinergic receptor activity in Alzheimer disease rats. Zhen Ci Yan Jiu (Chinese), 2011, 36(2): 90-94

[61]

ZhangG, YinH, ZhouYL, et al.. Capturing amplitude changes of low-frequency fluctuations in functional magnetic resonance imaging signal: a pilot acupuncture study on NeiGuan (PC6). J Altern Complement Med, 2012, 18(4): 387-393

[62]

ZhangP, GuanSS, JiangGH. Effects of electroa-cupuncture on expression of Abeta positive cells of the hippocampus and SOD activity in rats with streptozocin- Alzheimer’s disease. Zhongguo Zhen Jiu (Chinese), 2010, 30(12): 1007-1010

AI Summary AI Mindmap
PDF

140

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/